Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurexophilin and PC-esterase domain family member 2 (NXPE2) is a protein encoded by the NXPE2 gene in humans, located on chromosome 11, with known aliases including FAM55B and FLJ25224. It is a predicted membrane protein with structural similarity to members of the neurexophilin and PC-esterase domain families, with 559 amino acids in its canonical transcript. NXPE2's biological function is poorly understood. In mice, it has been shown to be required (together with Glycophorin A) for forming the TER-119 epitope used to identify erythroid lineage cells, suggesting possible roles in erythropoiesis; knockout mice demonstrate viability with only slight phenotypes in fibroblast proliferation and no gross hematologic effects. NXPE2 has not been consistently detected in human or murine red blood cell proteomes and is not well-established as a therapeutic target, receptor, or clinical biomarker. There is little evidence of direct involvement in common human diseases, although it has been reported in transcriptomic profiling of gastric cancer. No drugs or drug mechanisms are currently associated with NXPE2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurexophilin and PC-esterase domain family member 2 (NXPE2).